Announced details
Medical care, healthcare, cancer treatment, radiation therapy
ステラファーマ and SUMITOMO HEAVY INDUSTRIES,LTD. will jointly exhibit and present initiatives related to BNCT. Its relationship with Osaka Prefecture and Osaka Bio Headquarters is through the Osaka Pavilion at the exhibition. Capital and personnel relationships are Not disclosed.
SUMITOMO HEAVY INDUSTRIES,LTD. is a company involved in BNCT irradiation systems. Osaka Prefecture serves as the secretariat for Osaka Bio Headquarters. Other details are Not disclosed.
INTEX Osaka, Hall 6A and Hall 6B (1-5-102 Nanko-Kita, Suminoe-ku, Osaka)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Official World Health Expo Osaka 2026 website; Osaka Pavilion / WHX Osaka 2026 special website
| Item | Details |
|---|---|
| Names of Products / Services Covered | BNCT, BNCT irradiation system, Boron-based drugs for BNCT |
| Counterparty | SUMITOMO HEAVY INDUSTRIES,LTD., Osaka Prefecture, Osaka Bio Headquarters |
| Counterparty overview | SUMITOMO HEAVY INDUSTRIES,LTD. is a company involved in BNCT irradiation systems. Osaka Prefecture serves as the secretariat for Osaka Bio Headquarters. Other details are Not disclosed. |
| Relationship with the Company | ステラファーマ and SUMITOMO HEAVY INDUSTRIES,LTD. will jointly exhibit and present initiatives related to BNCT. Its relationship with Osaka Prefecture and Osaka Bio Headquarters is through the Osaka Pavilion at the exhibition. Capital and personnel relationships are Not disclosed. |
| Launch date | 2 July 2026 (scheduled; exhibition opening) |
| Applicable area | Medical care, healthcare, cancer treatment, radiation therapy |
| Location | INTEX Osaka, Hall 6A and Hall 6B (1-5-102 Nanko-Kita, Suminoe-ku, Osaka) |
| Source | Official World Health Expo Osaka 2026 website; Osaka Pavilion / WHX Osaka 2026 special website |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To promote understanding of BNCT and boron-based drugs, deepen interaction with medical and healthcare professionals, companies, research institutions and government agencies in Japan and overseas, and contribute to the development of BNCT.